Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $7.11 million. The enterprise value is $6.32 million.

Market Cap	7.11M
Enterprise Value	6.32M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

SLXN has 8.41 million shares outstanding.

Current Share Class	8.41M
Shares Outstanding	8.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.57%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.18
P/TBV Ratio	10.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.85

Current Ratio	3.85
Quick Ratio	3.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-452.67

Financial Efficiency

Return on equity (ROE) is -116.66% and return on invested capital (ROIC) is -73.07%.

Return on Equity (ROE)	-116.66%
Return on Assets (ROA)	-62.13%
Return on Invested Capital (ROIC)	-73.07%
Return on Capital Employed (ROCE)	-195.11%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.02
52-Week Price Change	n/a
50-Day Moving Average	1.82
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.26
Average Volume (20 Days)	31,104,398

Short Selling Information

The latest short interest is 1.60 million, so 18.99% of the outstanding shares have been sold short.

Short Interest	1.60M
Short Previous Month	222,445
Short % of Shares Out	18.99%
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.36M
Pretax Income	n/a
Net Income	-1.36M
EBITDA	-1.36M
EBIT	-1.36M
Earnings Per Share (EPS)	-$81.80

Balance Sheet

Cash & Cash Equivalents	788,000
Total Debt	n/a
Net Cash	788,000
Net Cash Per Share	$0.09
Equity (Book Value)	696,000
Book Value Per Share	4.67
Working Capital	687,000

Cash Flow

In the last 12 months, operating cash flow was -$794,000 and capital expenditures -$5,000, giving a free cash flow of -$799,000.

Operating Cash Flow	-794,000
Capital Expenditures	-5,000
Free Cash Flow	-799,000
FCF Per Share	-$0.09

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-19.06%
FCF Yield	-11.24%

Analyst Forecast

The average price target for SLXN is $9.00, which is 965.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	965.22%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 29, 2024. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date	Nov 29, 2024
Split Type	Reverse
Split Ratio	0.1111111:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1